Skip to main content
logo
Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.8480
-0.0258 (-2.95%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9120
+0.0640 (7.55%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Akso Health Group Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Net Income
-18.67-77.17-135.67-135.32-134.98-70.78-6.59-8.02-9.46-7.54
Depreciation & Amortization
2.372.863.362.752.151.080.020.01--
Asset Writedown & Restructuring Costs
16.789.59162.48162.48162.4881.24----
Provision & Write-off of Bad Debts
0.110.03-0.05-0.08-0.12.845.786.577.378.59
Other Operating Activities
-1.95-16.84-31.73-31.56-31.39-15.7-0.010.360.74-5.52
Change in Accounts Receivable
-0.44-1.58-2.72-1.79-0.86-0.61-0.36-0.020.330.24
Change in Inventory
-----0.521.041.271.50.58
Change in Accounts Payable
0.310.240.160.290.420.420.430.30.170.44
Change in Unearned Revenue
-5.81-0.814.187.029.866.653.451.830.220.32
Change in Income Taxes
0.060.080.10.03-0.04-0.010.020-0.020.04
Change in Other Net Operating Assets
-5.480.837.130.39-6.36-6.93-7.51-3.82-0.13-0.25
Operating Cash Flow
-12.79-2.777.264.221.18-1.28-3.74-1.191.35-0.16
Operating Cash Flow Growth (YoY)
-----12.88%-----

Investing Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Capital Expenditures
-0-87.85-175.69-87.92-0.15-0.14-0.13-0.07--
Cash Acquisitions
--18.75-37.5-65.63-93.75-103.13-112.5-84.38-56.25-28.13
Sale (Purchase) of Intangibles
-175.66-87.83--------
Investing Cash Flow
-163.46-189.71-215.95-160.93-105.91-109.27-112.63-83.68-54.72-27.36

Financing Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Short-Term Debt Issued
0.35---------
Total Debt Issued
0.35-2.15-4.65-2.32-2.154.32.15-0.18
Short-Term Debt Repaid
---------7.69-
Total Debt Repaid
------3.84-7.69-7.69-7.69-3.84
Net Debt Issued (Repaid)
0.35-2.15-4.65-2.32--1.7-3.39-5.54-7.69-3.67
Issuance of Common Stock
-66.66133.32164.6195.88198.9201.91170.62139.3469.67
Financing Cash Flow
0.3564.51128.67162.28195.88197.2198.52165.09131.6566

Net Cash Flow

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Foreign Exchange Rate Adjustments
-0.15-0.7-1.24-1.18-1.12-1.19-1.25-1.26-1.270.78
Net Cash Flow
-176.06-128.66-81.274.3890.0385.4680.978.9577.0139.26

Free Cash Flow

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Free Cash Flow
-12.79-90.61-168.43-83.711.02-1.42-3.87-1.261.35-0.16
Free Cash Flow Growth (YoY)
-----24.31%-----
Free Cash Flow Margin
-92.49%-632.02%-1134.83%-565.20%6.92%-12.25%-45.75%-23.16%55.97%-7.03%
Free Cash Flow Per Share
-0.02-0.11-0.36-0.100.00-0.00-0.03-0.010.03-0.01
Levered Free Cash Flow
-350.71-350.49-169.33-81.8946.6744.7-1.6-2.09-50.05-
Unlevered Free Cash Flow
-350.71-350.49-169.33-81.8946.6744.7-1.6-2.09-50.05-

Additional Metrics

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Cash Interest Paid
-----0.060.110.110.110.22
Cash Income Tax Paid
000000.010.020.020.020.02
Change in Working Capital
-11.35-1.248.865.943.020.04-2.94-0.442.061.36
SEC Filings: 10-K · 10-Q